ProfileGDS4718 / 1560475_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 18% 21% 17% 10% 16% 18% 12% 9% 13% 20% 17% 21% 17% 21% 16% 14% 19% 16% 30% 13% 13% 7% 12% 9% 14% 11% 14% 20% 6% 13% 14% 12% 12% 23% 22% 16% 17% 15% 18% 14% 9% 24% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1534220
GSM549102patient 115, normal, homogenized [OPG study]4.0838818
GSM549104patient 119, normal, homogenized [OPG study]4.1752521
GSM549108patient 138, normal, homogenized [OPG study]4.0808817
GSM549119patient 077, normal, homogenized [OPG study]3.7883110
GSM549133patient 032, cancer, homogenized [OPG study]3.9398916
GSM549139patient 042, cancer, homogenized [OPG study]4.0418618
GSM549099patient 107, normal, homogenized [OPG study]3.8762612
GSM549109patient 139, normal, homogenized [OPG study]3.769869
GSM549110patient 046, normal, homogenized [OPG study]3.8870913
GSM549114patient 063, normal, homogenized [OPG study]4.1169620
GSM549122patient 082, normal, homogenized [OPG study]4.0270917
GSM549134patient 033, cancer, homogenized [OPG study]4.1774521
GSM549136patient 036, cancer, homogenized [OPG study]3.9637217
GSM549140patient 044, cancer, homogenized [OPG study]4.1406321
GSM549111patient 047, normal, homogenized [OPG study]3.9679916
GSM549113patient 057, normal, homogenized [OPG study]3.8841414
GSM549132patient 031, cancer, homogenized [OPG study]4.111419
GSM549137patient 038, cancer, homogenized [OPG study]3.9902816
GSM549142patient 047, cancer, homogenized [OPG study]4.646930
GSM549100patient 110, normal, homogenized [OPG study]3.9097813
GSM549107patient 135, normal, homogenized [OPG study]3.8723713
GSM549115patient 068, normal, homogenized [OPG study]3.631767
GSM549116patient 072, normal, homogenized [OPG study]3.8309112
GSM549120patient 078, normal, homogenized [OPG study]3.752029
GSM549131patient 030, cancer, homogenized [OPG study]3.9005114
GSM549118patient 074, normal, homogenized [OPG study]3.8306811
GSM549129patient 027, cancer, homogenized [OPG study]3.9325914
GSM549123patient 088, normal, homogenized [OPG study]4.14320
GSM549124patient 006, cancer, homogenized [OPG study]3.668676
GSM549126patient 015, cancer, homogenized [OPG study]3.8558913
GSM549128patient 025, cancer, homogenized [OPG study]3.9135814
GSM549103patient 117, normal, homogenized [OPG study]3.8715312
GSM549117patient 073, normal, homogenized [OPG study]3.8583512
GSM549138patient 041, cancer, homogenized [OPG study]4.23523
GSM549141patient 045, cancer, homogenized [OPG study]4.1761822
GSM549130patient 028, cancer, homogenized [OPG study]4.003616
GSM549101patient 111, normal, homogenized [OPG study]4.0482517
GSM549105patient 128, normal, homogenized [OPG study]3.9818515
GSM549106patient 134, normal, homogenized [OPG study]4.0242118
GSM549112patient 048, normal, homogenized [OPG study]3.933114
GSM549125patient 011, cancer, homogenized [OPG study]3.764779
GSM549127patient 024, cancer, homogenized [OPG study]4.2674324
GSM549135patient 035, cancer, homogenized [OPG study]4.1944623